eukoencephalopathy with vanishing white matter: an intermediate phenotype in relation to a heterozygous mutation in EIF2B2

Authors

  • Belén Quintanilla-Carrillo Autoimmune and Rare Diseases Unit, Virgen del Rocío University Hospital, Seville, Spain https://orcid.org/0000-0003-4428-9419
  • Roberto Pertusa-Mataix Internal Medicine Department, Virgen del Rocío University Hospital, Seville, Spain
  • José Salvador García-Morillo Autoimmune and Rare Diseases Unit, Virgen del Rocío University Hospital, Seville, Spain https://orcid.org/0000-0003-1311-5483

DOI:

https://doi.org/10.32818/reccmi.a9n3a9

Keywords:

leukoencephalopathy with vanishing white matter, EIF2B2

Abstract

Presentation of an atypical case of vanishing white matter disease (VWM) in a young patient with compatible
clinical features and a pathogenic heterozygous mutation in the EIF2B2 gene. This case highlights the importance
of gene sequencing in the diagnosis of “rare diseases” such as leukodystrophies and present, for the first time, an
intermediate phenotype of VWM with adult onset associated with a heterozygous pathogenic mutation in EIF2B2.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Van der Knaap MS, Fogli A, Boespflug-Tanguy O, Abbink TEM, Schiffmann R.

Childhood ataxia with central nervous system hypomyelination / vanishing

white matter. 2003. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace

SE, Amemiya A, editors. GeneReviews®. Seattle (WA): University of Washington,

Seattle; 1993–2024. Accesible en: https://www.ncbi.nlm.nih.gov/

books/NBK1258/pdf/Bookshelf_NBK1258.pdf (último acceso nov. 2024).

Fogli A, Rodríguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, et

al. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J

Hum Genet. 2003; 72(6): 1544-50. doi: https://doi.org/10.1086/375404 (último DOI: https://doi.org/10.1086/375404

acceso nov. 2024).

Mierzewska H, van der Knaap M, Scheper G, Jurkiewicz E, Schmidt-Sidor B,

Szymańska K. Case report leukoencephalopathy with vanishing white matter

due to homozygous EIF2B2 gene mutation. First Polish cases. Folia Neuropathologica.

; 44(2): 144-148. Accesible en: https://www.termedia.

pl/Case-report-Leukoencephalopathy-with-vanishing-white-matter-dueto-

homozygous-EIF2B2-gene-mutation-First-Polish-cases,20,6223,1,1.html.

(ultimo acceso nov. 2024)

Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, et

al. The effect of genotype on the natural history of eIF2B-related leukodystrophies.

Neurology. 2004; 62(9): 1509-17. doi: https://doi.org/10.1212/01.

wnl.0000123259.67815.db (último acceso nov. 2024).

Tian Y, Liu Q, Zhou Y, Chen XY, Pan Y, Xu H, et al. Identification of a novel

heterozygous mutation in the EIF2B4 gene associated with vanishing white

matter disease. Front Bioeng Biotechnol. 2022; 10: 901452. doi: https://doi. DOI: https://doi.org/10.3389/fbioe.2022.1060249

org/10.3389/fbioe.2022.901452 (último acceso nov. 2024).

Sambati L, Agati R, Bacci A, Bianchi S, Capellari S. Vanishing white matter

disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an

unusual early onset and a long course. Neurol Sci. 2013; 4(7): 1235-8. doi:

https://doi.org/10.1007/s10072-012-1129-3 (último acceso nov. 2024). DOI: https://doi.org/10.1007/s10072-012-1129-3

Published

2024-12-31

How to Cite

1.
Quintanilla-Carrillo B, Pertusa-Mataix R, García-Morillo JS. eukoencephalopathy with vanishing white matter: an intermediate phenotype in relation to a heterozygous mutation in EIF2B2. Rev Esp Casos Clin Med Intern [Internet]. 2024 Dec. 31 [cited 2025 Feb. 5];9(3):134-6. Available from: https://www.reccmi.com/RECCMI/article/view/1071